Newsstand

Here's where you'll find a regularly updated, broad range of articles written by the AAMDSIF team, allied health organizations and news organizations. By staying well-informed, patients and families are practicing a form of self-support that will help them be more effective self-advocates when engaging with health care providers.

Foundation Update - June 2017

Originally Published: 06/14/2017
Foundation Update - June 2017

Study shows good results for older transplant patients

Originally Published: 06/13/2017
Many hematologic malignancies most commonly affect older adults. For example, the median age at diagnosis of acute myeloid leukemia (AML) is about 65 years, while the median age at presentation of MDS is more than 70 years, and the risk of MDS and AML continues to rise with advancing age. Historically, the potentially curative option of allogeneic hematopoietic stem cell transplant (HSCT) was not offered to most adults over the age of 65 due to increased relapse risk, the high frequency of comorbid conditions that make transplant-associated conditioning and immunosuppression difficult to...

New data presented at ASCO on secondary MDS/AML

Originally Published: 06/05/2017
Cancer patients with secondary malignancies have limited access to data regarding the possibility of their myelodysplastic syndrome (MDS), acute myeloid leukemia (AML), or both, being caused by the usage of certain chemotherapeutic agents that could possibly interfere with DNA. New data concludes, though, that the incidence of MDS and AML in ovarian and breast cancer patients was higher in patients exposed to DNA damaging agents. The data, presented at the 2017 American Society of Clinical Oncology (ASCO 2017) annual meeting in Chicago by Nicole Fulcher, et al, were gathered with the...

MDS Update - May 2017

Originally Published: 05/30/2017
MDS Update - May 2017

Aplastic Anemia Update - May 2017

Originally Published: 05/25/2017
Aplastic Anemia Update - May 2017

Foundation Update - May 2017

Originally Published: 05/19/2017
Foundation Update - May 2017

What you need to know about BMT reimbursement

Originally Published: 05/19/2017
The Centers for Medicare & Medicaid Services (CMS) issue the FY 2018 Inpatient Prospective Payment System proposed rule on April 14th. While we are disappointed that the proposed rule did not address allogeneic HCT cell acquisition, there are other significant changes that will impact your transplant center. 

Research in making blood stem cells in the lab advances

Originally Published: 05/18/2017
Researchers at Boston Children's Hospital have, for the first time, generated blood-forming stem cells in the lab using pluripotent stem cells, which can make virtually every cell type in the body. The advance, published today in the journal Nature, opens new avenues for research into the root causes of blood diseases and to creating immune-matched blood cells for treatment purposes, derived from patients' own cells. "We're tantalizingly close to generating bona fide human blood stem cells in a dish," says senior investigator George Daley, MD, PhD, who heads a research lab in Boston Children...

MDS patients in promising AML study on telomeres

Originally Published: 05/10/2017
Researchers said measuring DNA sections in cancer cells gave an "accurate indicator" of disease progression. Shorter DNA structures can leave chromosome ends exposed, accelerating cancer progression and drug resistance. The team believe the study could help doctors in choosing the most effective treatment for individual patients. Researchers from the university's School of Medicine said the tests can be used to predict the outcomes of patients with two different types of blood cancer - the bone marrow cancer myeloma and pre-leukaemia myelodysplastic syndromes (MDS). The latter is a bone...

On the horizon: Man-made bone marrow

Originally Published: 05/09/2017
Engineers at the University of California San Diego have developed biomimetic bone tissues that could one day provide new bone marrow for patients needing transplants. Bone marrow transplants are used to treat patients with bone marrow disease. Before a transplant, a patient is first given doses of radiation, sometimes in combination with drugs, to kill off any existing stem cells in the patient’s bone marrow. This pre-treatment is meant to improve success of the transplant by clearing up space in the marrow, allowing donor cells to survive and grow without competition from the patient’s own...